Review on analytical quality by design method of improved stability of drug
Clicks: 7
ID: 309245
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
1.8
/100
7 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #28 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The stability of pharmaceutical drugs is a critical factor affecting their efficacy, safety, and shelf-life. Traditional stability testing methods often lack efficiency and may not adequately predict real-world performance. Analytical Quality by Design (A QbD) has emerged as a systematic approach to ensure product quality by designing and controlling analytical procedures. This review explores the application of QbD methodologies in improving the stability of pharmaceutical drugs. The review begins with an overview of the principles of A QbD and its significance in pharmaceutical development. It then delves into the challenges associated with drug stability testing and the limitations of conventional approaches. Next, the application of A QbD principles in designing stability-indicating analytical methods is discussed, focusing on critical quality attributes (CQAs), risk assessment, and method development strategies. Finally, future directions and challenges in the application of A QbD for improving drug stability are discussed. Areas for further research and development, such as the integration of advanced analytical techniques and computational modelling, are identified to enhance the effectiveness of A QbD approaches in ensuring drug stability and quality.
| Reference Key |
imported_1761930121_6904eb8932192
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lalita Tyagi, Priyanshu, Ranveer Singh, Ankur Gupta, Dr. Sanjeev Kumar, Mohd. Irshad |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2024 |
| DOI |
10.62896/ijpdd.1.6.8
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.